V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330011709 | 330005047 | 1.6 | 48.8 | Palliative (P) | 2015-06-16 | 2015-06-17 | Docetaxel | N | N | 330016224 | DOCETAXEL |
| 330011710 | 330005048 | 1.6 | 53.6 | Curative (C) | 2016-10-03 | 2016-10-13 | Vinblastine | 02 | N | 330016234 | CAV |
| 330011711 | 330010744 | null | null | Palliative (P) | 2017-02-02 | 2017-02-02 | Trabectedin | N | N | 330016238 | TRABECTEDIN |
| 330011712 | 330005054 | 1.81 | 46.5 | Palliative (P) | 2016-06-20 | 2018-03-17 | NIVOLUMAB | 2 | N | 330016265 | VINBLASTINE |
| 330011713 | 330005055 | 1.7 | 102 | Palliative (P) | null | 2017-09-19 | Azacitidine | 02 | null | 330016269 | AZACITIDINE |
| 330011714 | 330005056 | 1.74 | 112 | Palliative (P) | 2016-04-28 | 2016-09-19 | Cisplatin + Doxorubicin | N | N | 330016281 | DA |
| 330011715 | 330005057 | 1.84 | 69.4 | Palliative (P) | 2014-03-22 | 2014-04-02 | Etoposide IV | 02 | N | 330016313 | ETOPOSIDE |
| 330011716 | 330010749 | 0 | 79.3 | Adjuvant (A) | 2016-05-24 | 2016-10-17 | DA 3 + 10 | N | null | 330016340 | CYCLOPHOSPHAMIDE + RITUXIMAB |
| 330011717 | 330008768 | 1.75 | 69.7 | Palliative (P) | 2016-09-12 | 2016-09-21 | IRINOTECAN + TEMOZOLOMIDE | 2 | N | 330016407 | IRINOTECAN + TEMOZOLOMIDE |
| 330011718 | 330005069 | 0 | 77.1 | null | 2015-09-12 | 2015-09-17 | Temozolomide 200mg/m2 | 02 | N | 330016460 | TEMOZOLOMIDE |
| 330011719 | 330005070 | 1.73 | null | Palliative (P) | 2015-08-17 | 2015-09-02 | Trabectedin | N | N | 330016499 | TRABECTEDIN |
| 330011720 | 330005071 | 1.79 | 58.6 | Curative (C) | null | 2015-05-07 | EURO-EWING | 02 | null | 330016511 | EURO-EWING |
| 330011721 | 330005078 | 1.78 | 65.1 | Palliative (P) | 2017-10-04 | 2017-10-05 | TEMOZOLOMIDE | N | N | 330016585 | NIVOLUMAB |
| 330011722 | 330011861 | 1.04 | null | Neo-adjuvant (N) | null | 2016-01-07 | GemCarbo Days 1+8 | null | null | 330016615 | GEMCARBO |
| 330011723 | 330005086 | 1.76 | 9.3 | Curative (C) | 2017-12-03 | 2017-12-17 | CYCLOPHOSPHAMIDE + RITUXIMAB | 02 | N | 330016666 | AZACITIDINE |
| 330011724 | 330008781 | null | 74 | Palliative (P) | 2016-07-13 | 2016-07-26 | EURO-EWING | N | N | 330016671 | EURO-EWING |
| 330011725 | 330008785 | 1.79 | 66 | Palliative (P) | 2018-06-29 | 2018-06-30 | Etoposide oral | N | N | 330016751 | ETOPOSIDE |
| 330011726 | 330005101 | 1.62 | 78.2 | Palliative (P) | 2016-09-06 | 2016-10-01 | Cisplatin + Etoposide (5 day) | 02 | N | 330016821 | AZACITIDINE |
| 330011727 | 330010761 | 1.83 | 45.2 | Palliative (P) | 2013-12-31 | 2014-02-25 | Methotrexate intrathecal | N | null | 330016828 | METHOTREXATE INTRATHECAL |
| 330011728 | 330008791 | 1.6 | null | Palliative (P) | 2014-10-17 | 2014-10-31 | CISPLATIN + ETOPOSIDE | N | N | 330016918 | CAV |
| 330011729 | 330005110 | 1.67 | null | Curative (C) | 2017-08-21 | 2017-09-10 | Cisplatin + Etoposide (5 day) | N | N | 330016923 | CISPLATIN + DOXORUBICIN |
| 330011730 | 330005113 | 1.8 | 119 | Palliative (P) | 2014-02-17 | 2014-02-21 | EW Rel rEECur Irinotecan/Temozolomide | 02 | N | 330016960 | IRINOTECAN + TEMOZOLOMIDE |
| 330011731 | 330010765 | 1.71 | null | Disease modification (D) | 2014-03-04 | 2014-03-04 | TEMOZOLOMIDE | N | N | 330016972 | CYCLOPHOSPHAMIDE + RITUXIMAB |
| 330011732 | 330012843 | null | 87.6 | Neo-adjuvant (N) | 2017-07-03 | 2017-07-03 | EW EuroEwing 99 : VIDE | Y | N | 330016977 | EURO-EWING |
| 330011733 | 330005122 | 1.42 | 69.3 | Curative (C) | 2014-12-22 | 2016-09-05 | Methotrexate Intrathecal (any age) | 2 | N | 330017013 | METHOTREXATE INTRATHECAL |
| 330011734 | 330005131 | 1.77 | null | Palliative (P) | 2015-06-29 | 2016-01-06 | Cisplatin + Doxorubicin | N | N | 330017052 | DA |
| 330011735 | 330012844 | null | 69.4 | Palliative (P) | 2013-10-05 | 2013-11-27 | ETOPOSIDE | N | null | 330017083 | ETOPOSIDE |
| 330011736 | 330010769 | 1.59 | 97 | Palliative (P) | 2016-03-20 | 2016-03-20 | Docetaxel 75mg/m2 (21 day) | 02 | N | 330017091 | DOCETAXEL |
| 330011737 | 330008806 | 1.83 | 89.7 | Palliative (P) | 2016-01-18 | 2017-03-27 | EURO-EWING | N | N | 330017120 | EURO-EWING |
| 330011738 | 330005136 | 1.8 | 97 | Palliative (P) | 2013-07-13 | 2013-08-01 | Trabectedin | N | null | 330017130 | TRABECTEDIN |
| 330011739 | 330010772 | 1.11 | 64.1 | Palliative (P) | null | 2015-09-29 | AML Int Guide HD Cytarabine (3 + 4) | null | null | 330017162 | CYTARABINE HIGH DOSE |
| 330011740 | 330005142 | 1.78 | 87.5 | Palliative (P) | 2017-06-14 | 2017-06-14 | Docetaxel 75mg/m2 (21 day) | null | N | 330017192 | DOCETAXEL |
| 330011741 | 330005144 | 1.74 | 71.65 | Palliative (P) | null | 2014-07-01 | Trabectedin | 2 | N | 330017225 | TRABECTEDIN |
| 330011742 | 330005146 | 1.5 | 59.4 | Palliative (P) | 2016-08-21 | 2016-08-27 | Vinblastine | 02 | N | 330017228 | CYCLOPHOSPHAMIDE + TOPOTECAN |
| 330011743 | 330008814 | 1.04 | 81.8 | Palliative (P) | 2017-01-21 | 2017-01-26 | EW Rel rEECur Irinotecan/Temozolomide | 02 | N | 330017243 | IRINOTECAN + TEMOZOLOMIDE |
| 330011744 | 330008816 | 1.04 | 77.4 | Curative (C) | null | 2015-11-14 | CNS HGG Temozolomide maintenance | null | null | 330017305 | CISPLATIN + DOXORUBICIN |
| 330011746 | 330005156 | 0 | 58.6 | Palliative (P) | 2014-10-02 | 2014-12-29 | AML Int Guide HD Cytarabine (3 + 4) | 02 | N | 330017337 | CYTARABINE HIGH DOSE |
| 330011747 | 330005162 | 1.58 | 81.2 | Palliative (P) | 2014-12-19 | 2014-12-20 | Docetaxel 75mg/m2 (21 day) | 02 | N | 330017399 | DOCETAXEL |
| 330011748 | 330005166 | 0 | 0 | Neo-adjuvant (N) | 2017-01-10 | 2017-01-10 | Cisplatin + Doxorubicin | N | N | 330017431 | CYCLOPHOSPHAMIDE + TOPOTECAN |
| 330011749 | 330005169 | 1.76 | 74.1 | Palliative (P) | 2016-07-12 | 2016-07-12 | Liposomal Doxorubicin (20mg/m2) | N | N | 330017436 | LIPOSOMAL DOXORUBICIN |
| 330011750 | 330005174 | 1.65 | null | Palliative (P) | 2015-02-05 | 2015-06-14 | GemCarbo Days 1+8 | null | null | 330017510 | GEMCARBO |
| 330011751 | 330005176 | 1.76 | 91.6 | Palliative (P) | 2017-09-17 | 2017-09-17 | Docetaxel 75mg/m2 (21 day) | N | N | 330017512 | DOCETAXEL |
| 330011752 | 330005179 | 0 | 23.6 | Palliative (P) | 2014-12-02 | 2015-04-07 | Cisplatin + Doxorubicin | N | N | 330017544 | NIVOLUMAB |
| 330011753 | 330005182 | 1.77 | null | Disease modification (D) | null | 2017-07-29 | EURO-EWING | N | N | 330017566 | EURO-EWING |
| 330011754 | 330005184 | null | 57.1 | Curative (C) | 2018-05-04 | 2018-05-08 | Temozolomide 200mg/m2 | 2 | N | 330017577 | AZACITIDINE |
| 330011755 | 330005187 | 0 | 49.2 | Palliative (P) | 2017-06-18 | 2017-06-21 | Irinotecan + Temozolomide | N | N | 330017647 | IRINOTECAN + TEMOZOLOMIDE |
| 330011758 | 330005202 | 0 | null | Palliative (P) | 2016-12-21 | 2017-01-29 | EURO-EWING | N | N | 330017807 | EURO-EWING |
| 330011759 | 330011877 | 1.81 | 97.5 | Curative (C) | 2017-10-10 | 2017-10-11 | CYCLOPHOSPHAMIDE + RITUXIMAB | N | N | 330017809 | DA |
| 330011761 | 330005218 | 1.59 | 114 | Palliative (P) | 2015-06-24 | 2015-08-07 | Temozolomide 150mg/m2 | 02 | null | 330017922 | AZACITIDINE |
| 330011762 | 330008847 | 1.64 | 68.6 | Palliative (P) | 2018-02-05 | 2018-02-05 | EW EuroEwing 2012 Arm A VIDE | N | null | 330017957 | EURO-EWING |